Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 4
Submit an article Journal homepage
1,557
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders

Christine Robinsona Hennepin Healthcare Research Institute (formerly Minneapolis Medical Research Foundation), Minneapolis, MN, USAView further author information
,
Carly Baehra Hennepin Healthcare Research Institute (formerly Minneapolis Medical Research Foundation), Minneapolis, MN, USA;b Department of Veterinary Population Medicine, University of Minnesota, Minneapolis, MN,, USAORCID Iconhttps://orcid.org/0000-0002-3395-6776View further author information
ORCID Icon,
Shirdi E. Schmielc Scripps Research Institute, La Jolla, CA, USAORCID Iconhttps://orcid.org/0000-0003-3041-4733View further author information
ORCID Icon,
Claudia Accetturod Department of Pharmaceutics, Universita degli Studi di Milano, Milan, ItalyView further author information
,
Daniel L. Muellere Center for Immunology, University of Minnesota, Minneapolis, MN, USA;f Department of Medicine, University of Minnesota, Minneapolis, MN, USAView further author information
&
Marco Pravetonia Hennepin Healthcare Research Institute (formerly Minneapolis Medical Research Foundation), Minneapolis, MN, USA;e Center for Immunology, University of Minnesota, Minneapolis, MN, USA;f Department of Medicine, University of Minnesota, Minneapolis, MN, USA;g Department of Pharmacology, University of Minnesota, Minneapolis, MN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1036-0184View further author information
ORCID Icon
Pages 909-917 | Received 28 Sep 2018, Accepted 05 Dec 2018, Published online: 20 Feb 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bethany Crouse, Li Zhang, Christine Robinson, Yuguang Ban, Jennifer R Vigliaturo, Sabita Roy & Marco Pravetoni. (2021) Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats. Human Vaccines & Immunotherapeutics 17:11, pages 4383-4392.
Read now

Articles from other publishers (14)

Bethany Crouse, Shannon M. Miller, Peter Muelken, Linda Hicks, Jennifer R. Vigliaturo, Cheryl L. Marker, Alonso G. P. Guedes, Paul R. Pentel, Jay T. Evans, Mark G. LeSage & Marco Pravetoni. (2023) A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. npj Vaccines 8:1.
Crossref
Shannon M. Miller, Bethany Crouse, Linda Hicks, Hardik Amin, Shelby Cole, Helene G. Bazin, David J. Burkhart, Marco Pravetoni & Jay T. Evans. (2023) A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice. npj Vaccines 8:1.
Crossref
Bethany Crouse, Carly Baehr, Dustin Hicks & Marco Pravetoni. (2023) IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice. The Journal of Immunology 210:9, pages 1272-1280.
Crossref
Cai He, Li Chen, Jingyun Yang, Zimin Chen, Hong Lei, Weiqi Hong, Xiangrong Song, Li Yang, Jiong Li, Wei Wang, Guobo Shen, Guangwen Lu & Xiawei Wei. (2023) Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants. Molecular Biomedicine 4:1.
Crossref
Gianna Triller, Evi P. Vlachou, Hamidreza Hashemi, Monique van Straaten, Johan P. Zeelen, Yosip Kelemen, Carly Baehr, Cheryl L. Marker, Sandra Ruf, Anna Svirina, Monica Chandra, Katharina Urban, Anastasia Gkeka, Sebastian Kruse, Andreas Baumann, Aubry K. Miller, Marc Bartel, Marco Pravetoni, C. Erec Stebbins, F. Nina Papavasiliou & Joseph P. Verdi. (2023) A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl. Cell Reports 42:2, pages 112049.
Crossref
Benedict T. Bloom & Mary-Jessimine Bushell. (2022) Vaccines against Drug Abuse—Are We There Yet?. Vaccines 10:6, pages 860.
Crossref
Julia Ritzau-Jost & Andreas Hutloff. (2021) T Cell/B Cell Interactions in the Establishment of Protective Immunity. Vaccines 9:10, pages 1074.
Crossref
Zhihui Liang, Yun Yang, Ge Yu, Haoru Zhu, Xinyu Xia, Chen Chen, Duo Fu, Min Li, Gang Cheng, Changying Xue, Li Shi, Hao Zeng & Bingbing Sun. (2021) Engineering aluminum hydroxyphosphate nanoparticles with well-controlled surface property to enhance humoral immune responses as vaccine adjuvants. Biomaterials 275, pages 120960.
Crossref
Carly Baehr, April Huseby Kelcher, Aaron Khaimraj, Dana E. Reed, Sujata G. Pandit, David AuCoin, Saadyah Averick & Marco Pravetoni. (2020) Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats. Journal of Pharmacology and Experimental Therapeutics 375:3, pages 469-477.
Crossref
Bethany Crouse, Christine Robinson, April Huseby Kelcher, Megan Laudenbach, Juan E. Abrahante & Marco Pravetoni. (2020) Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders. npj Vaccines 5:1.
Crossref
Michael D. Raleigh, Claudia Accetturo & Marco Pravetoni. (2020) Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity. Journal of Pharmacology and Experimental Therapeutics 374:3, pages 392-403.
Crossref
Valeria Gradinati, Federico Baruffaldi, Santhi Abbaraju, Megan Laudenbach, Rasidul Amin, Brian Gilger, Poonam Velagaleti & Marco Pravetoni. (2020) Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity. Vaccine 38:30, pages 4704-4712.
Crossref
Marco Pravetoni & Sandra D. Comer. (2019) Development of vaccines to treat opioid use disorders and reduce incidence of overdose. Neuropharmacology 158, pages 107662.
Crossref
Gianna Triller, Evi P. Vlachou, Hamidreza Hashemi, Monique van Straaten, Johan Zeelen, Yosip Kelemen, Carly Baehr, Cheryl L. Marker, Sandra Ruf, Anna Svirina, Sebastian Kruse, Andreas Baumann, Aubry Miller, Marc Bartel, Marco Pravetoni, C. Erec Stebbins, F. Nina Papavasiliou & Joseph Peter Verdi. (2022) An Epitope-Focused Trypanosome-Derived Vaccine Platform Elicits High-Affinity Antibodies and Immunity Against Fentanyl Effects. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.